Brief: Aptevo Therapeutics Announces Expansion Phase Of Lead Anti-Leukemia Drug Apvo436 In Adult Patients With Acute Myeloid Leukemia
27/05/2021 14:14
May 27 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS ANNOUNCES EXPANSION PHASE OF LEAD
ANTI-LEUKEMIA DRUG APVO436 IN ADULT PATIENTS WITH ACUTE MYELOID
LEUKEMIA
Source text for Eikon: [ID: https://bit.ly/3oZHzMX]
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary